Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 18.8B | 18.8B | 18.6B | 24.3B |
Cost of revenue | 13.7B | 13.5B | 13.4B | 17.5B |
Gross profit | 5.1B | 5.2B | 5.1B | 6.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.8B | 4.7B | 4.8B | 6.3B |
Other operating expenses | — | — | — | — |
Operating income | 312.4M | 528.7M | 335.9M | 464.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 95.3M | 109M | 103.6M | 145.7M |
Other income expense | 7.3M | -4.6M | -45.8M | -9.3M |
Pretax income | 218.2M | 415.1M | 186.5M | 309.9M |
Tax provision | 46.4M | 14.5M | 41M | 69.2M |
Net income | 171.8M | 400.6M | 145.5M | 240.7M |
Basic EPS | — | 0.7 | 0.3 | 0.4 |
Diluted EPS | — | 0.7 | 0.3 | 0.4 |
Basic average shares | — | 647.6M | 647.5M | 645.8M |
Diluted average shares | — | 651.9M | 650.9M | 648.8M |
EBITDA | 930.1M | 1.1B | 912.6M | 1.2B |
Net income from continuing op. | 171.8M | 400.6M | 145.5M | 240.7M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |